Russell Investments Group
BLFS icon

Russell Investments Group’s BioLife Solutions BLFS Stock Holding History

Russell Investments Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.75M Buy
274,470
+6,245
+2% +$146K 0.01% 1224
2026
Q1 		$5.12M Buy
268,225
+101,996
+61% +$2.25M 0.01% 1332
2025
Q4 		$4.02M Buy
166,229
+5,779
+4% +$151K ﹤0.01% 1458
2025
Q3 		$4.09M Sell
160,450
-51,709
-24% -$1.23M ﹤0.01% 1433
2025
Q2 		$4.57M Sell
212,159
-74,734
-26% -$1.68M 0.01% 1268
2025
Q1 		$6.55M Buy
286,893
+14,631
+5% +$385K 0.01% 1017
2024
Q4 		$7.07M Sell
272,262
-169,966
-38% -$4.23M 0.01% 987
2024
Q3 		$11.1M Buy
442,228
+78,230
+21% +$1.85M 0.02% 797
2024
Q2 		$7.8M Buy
363,998
+169,872
+88% +$3.3M 0.01% 943
2024
Q1 		$3.6M Buy
194,126
+11,076
+6% +$194K 0.01% 1316
2023
Q4 		$2.97M Sell
183,050
-1,993
-1% -$25.4K 0.01% 1404
2023
Q3 		$2.56M Sell
185,043
-47,490
-20% -$748K 0.01% 1406
2023
Q2 		$5.14M Buy
232,533
+15,320
+7% +$323K 0.01% 1076
2023
Q1 		$4.72M Sell
217,213
-8,069
-4% -$181K 0.01% 1130
2022
Q4 		$4.1M Sell
225,282
-12,066
-5% -$249K 0.01% 1206
2022
Q3 		$5.4M Buy
237,348
+15,159
+7% +$324K 0.01% 1012
2022
Q2 		$3.07M Sell
222,189
-231,568
-51% -$3.4M 0.01% 1354
2022
Q1 		$10.3M Sell
453,757
-59,114
-12% -$1.56M 0.02% 820
2021
Q4 		$19.1M Buy
512,871
+107,584
+27% +$4.62M 0.03% 628
2021
Q3 		$17.1M Sell
405,287
-73,184
-15% -$3.52M 0.03% 654
2021
Q2 		$21.3M Sell
478,471
-172,778
-27% -$6.09M 0.04% 587
2021
Q1 		$23.4M Sell
651,249
-189,390
-23% -$7.49M 0.04% 514
2020
Q4 		$33.5M Sell
840,639
-51,849
-6% -$1.77M 0.07% 336
2020
Q3 		$25.8M Buy
892,488
+218,316
+32% +$4.72M 0.06% 382
2020
Q2 		$11M Buy
674,172
+255,139
+61% +$3.52M 0.02% 686
2020
Q1 		$3.98M Sell
419,033
-136,506
-25% -$1.87M 0.01% 1086
2019
Q4 		$8.99M Sell
555,539
-27,304
-5% -$444K 0.02% 908
2019
Q3 		$9.69M Buy
582,843
+283,603
+95% +$5.32M 0.02% 878
2019
Q2 		$5.07M Buy
299,240
+208,786
+231% +$3.64M 0.01% 1216
2019
Q1 		$1.62M Buy
+90,454
New +$1.44M ﹤0.01% 1830

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Russell Investments Group's BLFS Position: Q2 2026 in Review

Russell Investments Group increased its BioLife Solutions (BLFS) stake by 2.3% in Q2 2026, buying an estimated $146K and bringing the position to 274,470 shares worth $7.75M. The position accounts for 0.01% of the portfolio, ranked #1224.

Russell Investments Group first reported a position in BLFS in Q1 2019 and has held it in 30 quarters since. The position peaked at $33.5M in Q4 2020. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Russell Investments Group held 274,470 shares of BioLife Solutions worth $7.75M as of Q2 2026.
  • Russell Investments Group bought 6,245 BioLife Solutions shares in Q2 2026, an estimated $146K.
  • BioLife Solutions made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1224 holding.
  • Russell Investments Group first reported a position in BioLife Solutions in Q1 2019 and has held it in 30 quarters since.
  • Russell Investments Group's BioLife Solutions position peaked at $33.5M in Q4 2020.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.